<h1>Regulatory enforcement: production halted at pharmaceutical unit after major compliance deficiencies found, show-cause issued by regulators</h1> Regulatory enforcement led to temporary cessation of manufacturing at a private pharmaceutical facility after joint CDSCO and state FDA inspectors recorded 216 deficiencies in production and related processes; a show-cause notice was issued and production halted pending further orders, reflecting supervisory powers to suspend operations and require corrective explanations.